VAERS reports by lot

Pfizer COVID-19 lot LM2221: VAERS reports

83 VAERS reports list lot LM2221 as a Pfizer COVID-19 vaccine, received between 2024-09-20 and 2024-12-26. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
83
Reports
6%
Marked serious
1
With a death outcome
4
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological5925%
General / Systemic (non-local)4218%
Injection-site / Local reaction3816%
Musculoskeletal2812%
Cardiac / Cardiovascular208%
Dermatological (non-injection-site)188%
Gastrointestinal125%
Allergic / Anaphylactic94%
Respiratory63%
Thrombotic / Hematological31%
Psychiatric / Neuropsychiatric31%

Where reports came from

U.S. state of the reporter, where given (top 12).

California10
Texas5
Ohio4
New York4
North Carolina4
Virginia3
Michigan3
Georgia3
Minnesota3
Washington3
Oregon3
North Dakota3

Reports by month received

2024-0915
2024-1043
2024-1113
2024-1212

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.